IBBQ vs. CNCR

Last updated Jul 14, 2026

IBBQ (Invesco Nasdaq Biotechnology ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds - IBBQ tracks the Nasdaq Biotechnology Index while CNCR tracks the Loncar Cancer Immunotherapy Index. Both are passively managed. IBBQ charges 0.19%/yr vs 0.79%/yr for CNCR.

Performance

IBBQ vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Invesco Nasdaq Biotechnology ETF (IBBQ) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

IBBQ

• 1D: -1.45%
• 1M: 10.41%
• 6M: 13.70%
• YTD: 15.12%
• 1Y: 49.59%
• 3Y*: 17.72%
• 5Y*: 6.46%
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• 6M: —
• YTD: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

IBBQ vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
IBBQ Invesco Nasdaq Biotechnology ETF	13.26%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

IBBQ vs. CNCR - Sectors Allocation Comparison

Sectors	IBBQ	CNCR
Healthcare	93.5%	96.6%
Consumer Defensive	0.2%	-
Consumer Cyclical	0.1%	-
Financial Services	0.1%	3.3%
Industrials	0.0%	-
Basic Materials	-	-
Communication Services	-	-
Energy	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

IBBQ vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBBQ

IBBQ Risk / Return Rank: 91
IBBQ Sharpe Ratio Rank: 91
IBBQ Sortino Ratio Rank: 90
IBBQ Omega Ratio Rank: 84
IBBQ Calmar Ratio Rank: 95
IBBQ Martin Ratio Rank: 93

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBBQ vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Invesco Nasdaq Biotechnology ETF (IBBQ) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IBBQ	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	2.45	—	—
Sortino ratio: Return per unit of downside risk	3.35	—	—
Omega ratio: Gain probability vs. loss probability	1.40	—	—
Calmar ratio: Return relative to maximum drawdown	5.98	—	—
Martin ratio: Return relative to average drawdown	18.92	—	—

Drawdowns

IBBQ vs. CNCR - Drawdown Comparison

The maximum IBBQ drawdown since its inception was -37.94%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for IBBQ and CNCR.

Drawdown Indicators

	IBBQ	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-37.94%	0.00%	-37.94%
Max Drawdown (1Y) Largest decline over 1 year	-8.34%	—	—
Max Drawdown (3Y) Largest decline over 3 years	-23.66%	—	—
Max Drawdown (5Y) Largest decline over 5 years	-37.94%	—	—
Current Drawdown Current decline from peak	-4.65%	0.00%	-4.65%
Average Drawdown Average peak-to-trough decline	-16.50%	0.00%	-16.50%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.63%	—	—

Volatility

Volatility by Period

	IBBQ	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	6.21%	—	—
Volatility (6M) Calculated over the trailing 6-month period	15.76%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	20.34%	0.00%	+20.34%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	22.02%	0.00%	+22.02%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	21.90%	0.00%	+21.90%

IBBQ vs. CNCR - Expense Ratio Comparison

IBBQ has a 0.19% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

IBBQ vs. CNCR - Dividend Comparison

IBBQ's dividend yield for the trailing twelve months is around 0.79%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
IBBQ Invesco Nasdaq Biotechnology ETF	0.79%	0.90%	1.14%	0.81%	0.76%	0.63%

Frequently Asked Questions

Which ETF is better, IBBQ or CNCR?

On fees, IBBQ is cheaper at 0.19% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, IBBQ or CNCR?

IBBQ is cheaper with a 0.19% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, IBBQ or CNCR?

IBBQ has the higher dividend yield at 0.79%, compared with 0.00% for CNCR.

What is the main difference between IBBQ and CNCR?

IBBQ tracks Nasdaq Biotechnology Index, while CNCR tracks Loncar Cancer Immunotherapy Index. They also come from different issuers: Invesco and Exchange Traded Concepts. Their fees differ too: 0.19% for IBBQ and 0.79% for CNCR.